Importantly, MUC1 and NRG1 are controlled by the Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1) for NSCLC survival and tumorigenesis with clinical relevance [54], while NRG1 is the major tumor suppressor gene postulated to be on 8p: it is in the correct location, is antiproliferative and is silenced in many breast cancers [55]. This evidence concerns the gene NRG1 and breast carcinoma.